Home   l   Media Relations   Investor Relations  l   Technology   Products   l





R & D HomeR & D EngineDevelopmentR & D PipelineProducts Home





   

All research and development (R & D) at AT-GC is focused on the goal of developing integrated & comprehensive treatments that will make a quantitative difference in patients’ lives. We believe that the best way to accomplish this

is to develop a clear  understanding of disease epidemiology– the networks of molecular mechanisms that underlie diseases. By combining this understanding with knowledge of therapeutically important differences that may exist between patients – differences either in disease pathways or in their responsiveness to particular drugs – we seek to enable “personalized medicine." By this we mean providing the right drugs, directed toward the right molecular targets, to the right patients, at the right time. Our approach is significantly different from other personalized medicine platforms that utilize patients genetic information to tailor novel drugs. Our proprietary doctor DNA TM platform technologies, utilizes patients own metabolic environment to synthesize the personalized drug. We feel very strongly that such an approach will take in to account all the variables that exist in the patient’s body to tailor the drug for maximum onsite efficiency.

 Pipeline

 The value of our focus on diseases with enormous global disease burden is illustrated by the pipeline of potential drugs we have in pre-clinical development, which includes molecules targeted to several key areas: Cancer therapeutics, infectious disease treatment, multi drug resistant infections and bio-defense.

 R&D Platform

 To add to our clinical pipeline, we have a large number of discovery-stage and preclinical programs, all driven by a powerful R&D engine that combines world-class biology in important disease pathways with an industry-leading technology platform. Over the last decade, this combination has made Avanti Therapeutics the partner of choice for many major pharmaceutical companies seeking to enhance their R&D productivity.

 Therapeutic Areas of focus

 R&D programs at AT-GC are focused in four key therapeutic areas, encompassing a range of important diseases:


               


Oncology


Infactious Diseases


Multi Drug Resistant Infections


Biodefense


 





About Us
Employment
Investors
Products
Locations
Contact Us
Site Map
Home